세계의 온라인 약국 시장

Global ePharmacies Market to Reach $323.8 Billion by 2030

The global market for ePharmacies estimated at US$97.9 Billion in the year 2023, is expected to reach US$323.8 Billion by 2030, growing at a CAGR of 18.6% over the period 2023-2030. Over-the-Counter Products, one of the segments analyzed in the report, is expected to record 17.8% CAGR and reach US$223.6 Billion by the end of the analysis period. Growth in the Prescription Medicine segment is estimated at 20.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $28.6 Billion, While China is Forecast to Grow at 17.7% CAGR

The ePharmacies market in the U.S. is estimated at US$28.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$55.2 Billion by the year 2030 trailing a CAGR of 17.7% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.1% and 16.2% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 13.9% CAGR.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 37 Featured) -

• 1mg Technologies Pvt. Ltd.
• Canada Drugs
• DocMorris NV
• Dr Fox Pharmacy
• eDrugstore.com
• Express Scripts Holding Company
• Giant Eagle, Inc.
• InternationalDrugMart.com
• MediSave
• Netmeds Marketplace Limited
• OptumRx, Inc.
• PlanetRx
• Rowlands Pharmacy
• The Kroger Company
• Walgreen Co.,
• Wal-Mart Stores, Inc.
• Zur Rose Group AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • ePharmacy on the Roll Despite Stumbling Blocks
  • Recent Market Activity
  • Inherent Benefits of the Channel - A Key Driving Factor
  • Regulations - A Game Changer for the ePharmacy Market
  • Legal Status of Online Sale of Medications - Prescription and Non-Prescription in Select Markets
  • ePharmacies - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
• 2. FOCUS ON SELECT PLAYERS
  • 1mg Technologies Pvt. Ltd. (India)
  • Canada Drugs (Canada)
  • Dr Fox Pharmacy (UK)
  • eDrugstore.com (USA)
  • Express Scripts Holding Company (USA)
  • Giant Eagle, Inc. (USA)
  • InternationalDrugMart.com (Cyprus)
  • Lloyds Pharmacy Ltd. (UK)
  • MediSave (Canada)
  • Netmeds Marketplace Limited (India)
  • OptumRx, Inc. (USA)
  • PlanetRx (UK)
  • Rowlands Pharmacy (UK)
  • Sanicare-Apotheke (Germany)
  • T.mall.com (China)
  • The Kroger Company (USA)
  • Walgreen Co. (USA)
  • Wal-Mart Stores, Inc. (USA)
  • Yihaodian (China)
  • Zur Rose Group AG (Switzerland)
  • DocMorris NV (Netherlands)
• 3. MARKET TRENDS & DRIVERS
  • ePharmacies Bring Potential Value to Customers
  • ePharmacies Enable Better Care and Enhance Quality of Life
  • Prescription Drugs Fuel the Growth of Electronic Pharmacies
  • Increasing Healthcare Spending in Emerging Markets: Opportunities in Store
  • Ballooning Elderly Population: The Vital Growth Driver
  • Internet Globalizes Drug Sales through ePharmacies
  • Expanding Internet User Base: A Key Driving Force
  • Rising Smartphone Usage Supports Growing Adoption
  • Re-importation or Cross Border Drug Sales: An Area of Concern in the US
  • Cyber Crime in the Name of ePharmacies on the Rise
  • Online Pharmacies Growth Leads to Global Presence of Counterfeit Drugs
  • Perils of Counterfeit and Fake Drugs
  • Operation Pangea X - A Major Crackdown against Illegal Online Pharmacies
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World ePharmacies Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for ePharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for ePharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Over-the-Counter Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Over-the-Counter Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for Over-the-Counter Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Prescription Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Prescription Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Prescription Medicine by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 11: USA Recent Past, Current & Future Analysis for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 12: USA Historic Review for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 13: USA 16-Year Perspective for ePharmacies by Product - Percentage Breakdown of Value Revenues for Over-the-Counter Products and Prescription Medicine for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 14: Canada Recent Past, Current & Future Analysis for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 15: Canada Historic Review for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 16: Canada 16-Year Perspective for ePharmacies by Product - Percentage Breakdown of Value Revenues for Over-the-Counter Products and Prescription Medicine for the Years 2014, 2024 & 2030
• JAPAN
  • ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 17: Japan Recent Past, Current & Future Analysis for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 18: Japan Historic Review for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 19: Japan 16-Year Perspective for ePharmacies by Product - Percentage Breakdown of Value Revenues for Over-the-Counter Products and Prescription Medicine for the Years 2014, 2024 & 2030
• CHINA
  • ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 20: China Recent Past, Current & Future Analysis for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 21: China Historic Review for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: China 16-Year Perspective for ePharmacies by Product - Percentage Breakdown of Value Revenues for Over-the-Counter Products and Prescription Medicine for the Years 2014, 2024 & 2030
• EUROPE
  • ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 23: Europe Recent Past, Current & Future Analysis for ePharmacies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 24: Europe Historic Review for ePharmacies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: Europe 16-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 26: Europe Recent Past, Current & Future Analysis for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Europe Historic Review for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: Europe 16-Year Perspective for ePharmacies by Product - Percentage Breakdown of Value Revenues for Over-the-Counter Products and Prescription Medicine for the Years 2014, 2024 & 2030
• FRANCE
  • ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 29: France Recent Past, Current & Future Analysis for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: France Historic Review for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: France 16-Year Perspective for ePharmacies by Product - Percentage Breakdown of Value Revenues for Over-the-Counter Products and Prescription Medicine for the Years 2014, 2024 & 2030
• GERMANY
  • ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 32: Germany Recent Past, Current & Future Analysis for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Germany Historic Review for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: Germany 16-Year Perspective for ePharmacies by Product - Percentage Breakdown of Value Revenues for Over-the-Counter Products and Prescription Medicine for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 35: Italy Recent Past, Current & Future Analysis for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Italy Historic Review for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: Italy 16-Year Perspective for ePharmacies by Product - Percentage Breakdown of Value Revenues for Over-the-Counter Products and Prescription Medicine for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 38: UK Recent Past, Current & Future Analysis for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: UK Historic Review for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: UK 16-Year Perspective for ePharmacies by Product - Percentage Breakdown of Value Revenues for Over-the-Counter Products and Prescription Medicine for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 41: Rest of Europe Recent Past, Current & Future Analysis for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: Rest of Europe Historic Review for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: Rest of Europe 16-Year Perspective for ePharmacies by Product - Percentage Breakdown of Value Revenues for Over-the-Counter Products and Prescription Medicine for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 44: Asia-Pacific Recent Past, Current & Future Analysis for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Asia-Pacific Historic Review for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: Asia-Pacific 16-Year Perspective for ePharmacies by Product - Percentage Breakdown of Value Revenues for Over-the-Counter Products and Prescription Medicine for the Years 2014, 2024 & 2030
• REST OF WORLD
  • TABLE 47: Rest of World Recent Past, Current & Future Analysis for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Rest of World Historic Review for ePharmacies by Product - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: Rest of World 16-Year Perspective for ePharmacies by Product - Percentage Breakdown of Value Revenues for Over-the-Counter Products and Prescription Medicine for the Years 2014, 2024 & 2030

IV. COMPETITION